Article
RePOWER: An International, Prospective, Non-Interventional Registry of Patients With Primary Mitochondrial Myopathy.
Clinical genetics - 1 Jan 2026
Karaa Amel, Goldstein Amy, Cohen Bruce H, Haas Richard H, Vockley Jerry, Gorman Gráinne S, Mancuso Michelangelo
Abstract excerpt
Primary mitochondrial myopathies (PMMs), a group of genetic mitochondrial oxidative phosphorylation disorders, primarily affect skeletal muscle function. No approved treatments for PMM exist, and patient information is limited. The international RePOWER registry (NCT03048617) assessed genotypic and phenotypic relationships in PMM and identified patients for MMPOWER-3 (elamipretide Phase 3 study). RePOWER enrolled...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.